Merck withdraws marketing application for Keytruda in Europe
(Reuters) - Merck& Co Inc said on Friday it had withdrawn its European application for Keytruda as a combination treatment for patients with an advanced stage of non-small cell lung cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Health | Lung Cancer | Marketing | Merck | Non-Small Cell Lung Cancer